Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma

Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma

Surgical resection remains a first-line therapy for glioblastoma multiforme (GBM). Increased extent of resection (EOR) of noncontrast-enhancing regions in T2-weighted MRI images (T2-EOR) provides a survival benefit for GBM patients receiving standard radio/chemotherapy. However, whether it also impr...

Full description

Bibliographic Details
Main Authors: Xiaohan Chi, Yi Wang, Chunzhao Li, Xijian Huang, Hua Gao, Yang Zhang, Nan Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
extent of resection
immunotherapeutic efficacy
cancer treatment vaccine
HSPPC-96
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.877190/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.877190/full

Similar Items